ANGPTL3 and ANGPTL4 are angiopoietin-like proteins secreted and expressed mainly by the liver, their role being the regulation of triglyceride metabolism by inhibiting the lipolysis of triglyceride-rich lipoproteins. During different nutritional states (feeding/fasting) the levels of the circulating triglycerides are regulated by Angptl3 and Angptl4 through differential inhibition of Lipoprotein lipase (LPL) as shown by the experimental data. The molecular structure of ANGPTL3 is similar to that of the angiopoietins (vascular endothelial growth factors). Deletion mutants of human Angiopoietin 5 were used in order to demonstrate that the N-terminal domain (fragment 17-207) and not the C-terminal fibrinogen-like domain (fragment 207-460) increased the plasma triglyceride levels in mice.
|Keywords:||ANG-5, ANGPT5, ANGPTL3, Angiopoietin-5, Angiopoietin-like protein 3, Angiopoietin-related protein 3|
|Expressed in:||Human cells|
|KEGG ID :||K22288 | Find alternatives|
|UniProt ID :||Q9Y5C1 | Find alternatives|
|Gene ID||GeneID 27329 | Find alternatives|
Handling & Safety
|Shipping:||+4°C (International: +4°C)|
Our products are for laboratory research use only: Not for administration to humans!